{"organizations": [], "uuid": "6020b2a2f00b22b968b67091e3d11ac5e8a68440", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-unitedhealth-reports-q4-adjusted-e/brief-unitedhealth-reports-q4-adjusted-eps-of-2-59-idUSL8N1PB32H", "country": "US", "domain_rank": 408, "title": "BRIEF-UnitedHealth Reports Q4 Adjusted EPS Of $2.59", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-16T13:25:00.000+02:00", "replies_count": 0, "uuid": "6020b2a2f00b22b968b67091e3d11ac5e8a68440"}, "author": "", "url": "https://www.reuters.com/article/brief-unitedhealth-reports-q4-adjusted-e/brief-unitedhealth-reports-q4-adjusted-eps-of-2-59-idUSL8N1PB32H", "ord_in_thread": 0, "title": "BRIEF-UnitedHealth Reports Q4 Adjusted EPS Of $2.59", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "reuters staff", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "thomson reuters", "sentiment": "none"}, {"name": "unitedhealth group inc", "sentiment": "none"}, {"name": "unitedhealth", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "January 16, 2018 / 11:25 AM / Updated 27 minutes ago BRIEF-UnitedHealth Reports Q4 Adjusted EPS Of $2.59 Reuters Staff \nJan 16 (Reuters) - UnitedHealth Group Inc: \n* UNITEDHEALTH GROUP REPORTS 2017 RESULTS HIGHLIGHTED BY CONTINUED STRONG AND DIVERSIFIED GROWTH * FY 2017 EARNINGS PER SHARE $10.72 * FY 2017 ADJUSTED EARNINGS PER SHARE $10.07 \n* Q4 EARNINGS PER SHARE $3.65; Q4 ADJUSTED EARNINGS PER SHARE $2.59 \n* QTRLY REVENUE $52.1 BILLION VERSUS $47.5 BILLION LAST YEAR \n* Q4 EARNINGS PER SHARE VIEW $2.51, REVENUE VIEW $51.51 BILLION -- THOMSON REUTERS I/B/E/S \n* SEES FY 2018 ADJUSTED EARNINGS PER SHARE $12.30 TO $12.60 * SEES FY 2018 EARNINGS PER SHARE $11.65 TO $11.95 \n* FY2018 EARNINGS PER SHARE VIEW $11.47, REVENUE VIEW $223.76 BILLION -- THOMSON REUTERS I/B/E/S \n* Q4 2017 CONSOLIDATED MEDICAL CARE RATIO OF 82.2 PERCENT REFLECTED CONSISTENT MEDICAL COST TRENDS \n* CASH FLOWS FROM OPERATIONS FOR FY 2018 ARE EXPECTED TO RANGE FROM $15 BILLION TO $15.5 BILLION \n* DUE TO U.S. TAX REFORM, 2017 NET EARNINGS INCLUDED $1.22/SHARE NON-CASH BENEFIT FROM REVALUATION OF NET DEFERRED TAX LIABILITY \n* REVISED ITS 2018 FINANCIAL OUTLOOK TO REFLECT EFFECTS OF U.S. CORPORATE TAX LAW CHANGES \n* UNITEDHEALTH SEES 2018 UNITEDHEALTH GROUP MEDICAL CARE RATIO 81.5 PERCENT, +/- 50 BPS \n* Q4 NET EARNINGS OF $3.65 PER SHARE INCLUDED ONE-TIME, NON-CASH DEFERRED TAX BENEFIT OF $1.21 PER SHARE \n* UNITEDHEALTH SEES 2018 SHARE REPURCHASES OF $3,000 MILLION - $4,000 MILLION \n* TAX CUTS & JOBS ACT RESULTED IN $1.2 BILLION FAVORABLE NON-CASH REVALUATION OF COâ€˜S U.S. NET DEFERRED TAX LIABILITY \n* SEES FY 2018 REVENUE $223 BILLION - $225 BILLION Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-01-16T13:25:00.000+02:00", "crawled": "2018-01-16T13:39:24.037+02:00", "highlightTitle": ""}